What is bioidentical hormone therapy?
Direct Answer
Bioidentical hormone therapy (BHT) refers to use of hormones that are chemically identical to those produced by the human body. Most modern, FDA-approved hormone therapies—including 17-beta estradiol and micronized progesterone—are bioidentical, as they match the molecular structure of natural hormones exactly.
Detailed Explanation
The term "bioidentical" has become one of the most discussed and often misunderstood topics in the menopause landscape. To navigate these discussions confidently, it's essential to understand the difference between the molecular structure of a hormone and how that hormone is manufactured and regulated.
At its core, "bioidentical" is a molecular description. It means that the hormone has the exact same chemical and molecular structure as the hormones naturally produced in a woman's ovaries (specifically 17-beta estradiol and progesterone). Because the structure is identical, these hormones fit into the body's hormone receptors in the brain, heart, bones, and skin like a "key in a lock," mimicking the biological actions of natural hormones more precisely than older, synthetic versions.
Synthetic hormones, such as Premarin (conjugated equine estrogens derived from pregnant mare's urine) or Provera (medroxyprogesterone acetate), were the standard of care for decades. While effective at treating symptoms, they have a slightly different molecular structure than human hormones. This difference means they may interact with receptors in unintended ways, which contributes to some of the side effects and risks (such as the slight increase in breast cancer risk associated with synthetic progestins) seen in older clinical trials like the Women's Health Initiative.
A common misconception is that "bioidentical" is synonymous with "custom-compounded." In reality, the vast majority of modern, FDA-approved hormone therapies are bioidentical. These include: 1. 17-beta Estradiol: Available in patches, gels, sprays, and some oral tablets. 2. Micronized Progesterone: Often prescribed as Prometrium or its generic equivalents.
These FDA-approved bioidentical hormones are derived from plant sources (typically soy or yams) and are manufactured in highly regulated laboratories. They undergo rigorous testing for purity, potency, and safety, and their efficacy is proven through large-scale clinical trials. Because they are regulated, you can be certain that every dose contains exactly what is on the label.
Custom-compounded bioidentical hormones, on the other hand, are prepared by a pharmacist based on an individual prescription. While they are often marketed as "safer" or "customized" for a woman's unique needs through saliva or blood testing, major medical societies like the North American Menopause Society (NAMS) and the Endocrine Society advise caution. Compounded hormones lack FDA oversight, meaning their purity and potency can vary significantly between batches. Furthermore, there is no evidence that the "customization" based on one-time hormone testing provides better outcomes than standard, regulated doses.
The clinical transition toward bioidentical hormones—specifically transdermal estradiol and micronized progesterone—represented a "gold standard" shift in safety. Transdermal estradiol (absorbed through the skin) does not increase the risk of blood clots, and micronized progesterone has not been linked to an increased risk of breast cancer in observational studies lasting up to five years.
Choosing between bioidentical options is a personalized decision. Most clinicians prefer FDA-approved bioidentical formulations because they offer the biological benefits of "body-identical" hormones with the safety guarantees of a regulated medication. This allows for a more predictable and safer approach to managing menopause symptoms and protecting long-term bone and heart health.
In conclusion, "bioidentical" simply means a hormone that matches your own body's chemistry. For the majority of women, the safest and most effective way to access these hormones is through standard, FDA-regulated prescriptions. By understanding the molecular reality of these treatments, women can move past marketing hype and focus on the evidence-based safety and efficacy of their therapy.
Evidence Context
The molecular identity of bioidentical hormones is an established chemical fact. We distinguish between "FDA-approved bioidenticals" (regulated and tested) and "compounded bioidenticals" (non-regulated). We prioritze NAMS and Endocrine Society guidelines which favor regulated formulations.